82
Blockade of CD95 signaling in 4T1 cancer cells markedly reduced tumor growth, inhibited tumor metastasis in vivo, and prolonged survival of tumor-bearing mice Liu et al.
178
Colon cancer Expression of CD95L on colon cancer cells greatly increased their local growth and ability to metastasize to the liver Li et al.
150
CD95 driven liver metastasis of CD95 stimulated colon cancer cells is dependent on oncogenic Kras
Hoogwater et al.
70
Radiofrequency ablation of colorectal liver metastases induces hypoxia that causes autocrine activation of CD95 promoting local invasion and accelerated metastasis outgrowth Nijkamp et al.
75
CD95 triggering resulted in an increased metastatic ability and activation of EMT in cells resistant to oxaliplatin
Ametller et al.
125
CD95 stimulation induced phosphorylation of phospholipase C-g1 through the platelet-derived growth factor receptor-b, resulting in phosphatidylinositol (4,5)-bisphosphate (PIP2) hydrolysis, liberating cofilin from the plasma membrane to initiate cortical actin remodeling in turn increasing tumor cell invasion
Steller et al.
81
Gastrointestinal cancer CD95 stimulation induced ERK1/2 driven EMT and motility Zheng et al.
112
Glioblastoma Stimulation of CD95 by CD95L induced invasiveness through recruitment of the Yes src kinase and the p85 subunit of phosphatidylinositol 3-kinase to CD95, resulting in activation of GSK3β and subsequent expression of matrix metalloproteinases Kleber et al.
74
Hepatocellular carcinoma Neutralizing CD95L in a transgenic model of hepatocellular carcinogenesis reduced both inflammation and tumor formation Nakamoto et al.
179
Mice with a point mutation in the CD95 DD expressed only on nonhematopoietic cells developed spontaneous liver cancer independent of the lack of apoptosis induction through CD95
Park et al.
180
Mice with tissue specific deletion of CD95 in hepatocytes showed a 50% reduced occurrence of DEN induced liver cancer Chen et al.
44
Histiocytic sarcoma Cancer formed in the liver of mice engineered to express only soluble and lacking expression of membrane bound CD95L
La et al.
78
Lung cancer CD95 overexpressing Lewis lung carcinoma (3LL) cells grew faster in vivo in syngeneic mice when compared with control transfected cells Lee et al.
68
CD95 ligation-induced 3LL cells to produce the proinflammatory factor PGE2 by activating p38 contributing to CD95 ligation-induced chemoattraction of myeloid-derived suppressor cells Zhang et al.
69
CD95 mediated activation of NF-kB was found to contribute to the resistance of lung cancer to a EGFR tyrosine kinase inhibitor Bivona et al.
79
Melanoma Stimulation of B16 cells by exosome-derived CD95L in vitro activates NF-kB and ERK, and in vivo increases migration to the lung Cai et al.
181
Ovarian cancer Mice lacking expression of CD95 in the surface epithelial cells of the ovaries barely developed cancer in a mouse model of endometrioid ovarian cancer driven by oncogenic Kras and deletion of pten Chen et al.
44
Tissue specific deletion of CD95 in the ovaries resulted in an increase in inflammation in the ovaries and reduced tumor development in a model of low grade ovarian cancer driven by oncogenic Kras and deletion of pten. All outgrowing cancer cells still expressed at least one allele of wt CD95
Hadji et al.
119
Pancreatic cancer Stimulation of TRAF2 overexpressing cells resulted in increased invasiveness by activating NF-kB and AP-1 resulting in upregulated uPA
Trauzold et al.
73
Stimulation of CD95 on FADD knockdown cell lines mediates cell survival by recruiting calmodulin and Src resulting in activation of ERK Yuan et al.
72
CD95 was identified as upregulated on cancer stem cells driving cell cycle progression by using Sck. Invasiveness and tumor growth could be inhibited in vivo by blocking CD95L
Teodorczyk et al.
83
Thyroid cancer Stimulation of CD95 induced cell growth through ERK, NF-kB, and AP-1 Mitsiades et al.
